logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Catherine Owen Adams Succeeds Steve Davis As CEO At Acadia Pharmaceuticals Inc.

Sep 23, 2024•about 1 year ago

Position

Chief Executive Officer

Company

Acadia Pharmaceuticals

Catherine Owen Adams
San Diego

Description

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) has announced the appointment of Catherine Owen Adams as the new Chief Executive Officer (CEO), succeeding Steve Davis. Catherine Owen Adams brings extensive pharmaceutical industry experience to her new role, with proven leadership in driving growth and innovation.

Company Information

Company

Acadia Pharmaceuticals

Location

San Diego, California, United States

About

Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis and the first and only FDA-approved drug for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Prader-Willi syndrome, Alzheimer’s disease psychosis and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months